Health benefits of oral contraceptives (Q34089756)

30 July 2017

1 reference

title

Health benefits of oral contraceptives (English)

1 reference

30 July 2017

Jensen JT

1

1 reference

PubMed ID

11091985

30 July 2017

Speroff L

series ordinal

2

1 reference

30 July 2017

1 December 2000

1 reference

Obstetrics and Gynecology Clinics of North America

30 July 2017

1 reference

30 July 2017

27

1 reference

30 July 2017

4

1 reference

30 July 2017

705-721

1 reference

The reduction in risk of ovarian cancer associated with oral-contraceptive use

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The evaluation and management of acne: economic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Risk factors for benign breast disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The role of oral contraceptives in the treatment of hyperandrogenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral contraceptive use and risk of benign breast disease in a French case-control study of young women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Use of oral contraceptives and uterine fibroids: results from a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Acute adolescent menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Clinician/patient interaction: communicating the benefits and risks of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral Contraceptive Use and Risk of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Menstrual migraine. Methods of prevention and control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral contraceptives and colorectal tumors. A review of epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Bone mineral density in young women with long-standing amenorrhea: limited effect of hormone replacement therapy with ethinylestradiol and desogestrel.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Unintended Pregnancy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral contraceptive health benefits: perception versus reality

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Bone mineral density in postmenopausal women as determined by prior oral contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral contraceptive type and functional ovarian cysts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Hormonal correlates of acne and hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

A case of menstruation-associated asthma: treatment with oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral-contraceptive use and risk of hip fracture: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Contraceptive methods and risk of pelvic endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

How effective are contraceptives? The determination and measurement of pregnancy rates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

A case-control study of oral contraceptive use and invasive epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Epidemiology of endometriosis among parous women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The prevalence of acne on the basis of physical examination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Factors influencing the prevalence and severity of dysmenorrhoea in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Perceptions of contraceptive effectiveness and health effects of oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

The use of oral contraceptives by adolescents for contraception, menstrual cycle problems or acne

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Epidemiology of endometriosis in women attending family planning clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Clinical experience with triphasic oral contraceptive (Triquilar) in 527 women in China

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

Characteristics relating to ovarian cancer risk: implications for prevention and detection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

A survey of adolescent dysmenorrhea and premenstrual symptom frequency. A model program for prevention, detection, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

An open study of Triphasil and Diane 50 in the treatment of acne

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970169-8

7 January 2021

10.1016/S0889-8545(05)70169-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11091985